Vivek Subbiah: ASCO elections are open! Delighted to endorse Erika Hamilton
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on LinkedIn:
“ASCO elections are open!
Please vote early and make your vote count.
I’m delighted to endorse Dr. Erika Hamilton, MD for the Nominating Committee in an undesignated spot in the ASCO Election for 2025.
Dr. Hamilton is a world renowned leader in breast cancer drug development. She serves as Chair, Breast Executive Committee and Director of the Breast and Gynecologic Cancer Research Program at Sarah Cannon Research Institute.
She sees patients from standard care to phase I-III trials SCRI Oncology Partners, The US Oncology Network.
Dr. Hamilton is the past Chair of ASCO’s Scientific Committee for Metastatic Breast Cancer (2019-2020), serves on the Board of Directors for Susan G. Komen Middle Tennessee, and is an Associate Editor for Clinical Breast Cancer. She was named to the Women to Watch Class of 2021 for Nashville Medical News and in ASCO’s Leadership Development Class (2021-2022).
The voting period closes on Tuesday, December 3, 2024, at 3:00 PM Eastern Standard Time, USA.
Learn more about her and the 12 other amazing candidates. Make your vote count!”
More posts featuring Vivek Subbiah.
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer.
He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials. He has also received the Yvonne Award 2024 by OncoDaily in the “Voice of Oncology” category.
Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee.
She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023